BoYuan RunSheng Pharma (Hangzhou) Co., Ltd.   Report issue

For profit Phase 2
Founded: Shandong China (2005)
Status: No NME R&D (2005)

Organization Overview

First Clinical Trial
2020
NCT04077866
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

BoYuan RunSheng Pharma (Hangzhou) Co., Ltd.